Clinical Laboratory Service Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Clinical Laboratory Service Market, By Test Type

7.1.  Clinical Laboratory Service Market, By Test Type, 2020-2030

7.1.1.    Human & Tumor Genetics

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Clinical Chemistry

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Medical Microbiology & Cytology

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Other Esoteric Tests

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Clinical Laboratory Service Market, By Service Provider

8.1.  Clinical Laboratory Service Market, By Service Provider, 2020-2030

8.1.1.    Hospital-Based Laboratories

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Stand-Alone Laboratories

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Clinic-Based Laboratories

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Clinical Laboratory Service Market, By Application

9.1.  Clinical Laboratory Service Market, By Application, 2020-2030

9.1.1.    Bioanalytical & Lab Chemistry Services

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Toxicology Testing Services

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Cell & Gene Therapy Related Services

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Preclinical & Clinical Trial Related Services

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Drug Discovery & Development Related Services

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    Others

9.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Clinical Laboratory Service Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Test Type (2016-2030)

10.1.2.  Market Revenue and Forecast, By Service Provider (2016-2030)

10.1.3.  Market Revenue and Forecast, By Application (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.1.4.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.1.4.3.      Market Revenue and Forecast, By Application (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.1.5.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.1.5.3.      Market Revenue and Forecast, By Application (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Test Type (2016-2030)

10.2.2.  Market Revenue and Forecast, By Service Provider (2016-2030)

10.2.3.  Market Revenue and Forecast, By Application (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.2.4.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.2.4.3.      Market Revenue and Forecast, By Application (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.2.5.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.2.5.3.      Market Revenue and Forecast, By Application (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.2.6.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.2.6.3.      Market Revenue and Forecast, By Application (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.2.7.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.2.7.3.      Market Revenue and Forecast, By Application (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Test Type (2016-2030)

10.3.2.  Market Revenue and Forecast, By Service Provider (2016-2030)

10.3.3.  Market Revenue and Forecast, By Application (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.3.4.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.3.4.3.      Market Revenue and Forecast, By Application (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.3.5.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.3.5.3.      Market Revenue and Forecast, By Application (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.3.6.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.3.6.3.      Market Revenue and Forecast, By Application (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.3.7.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.3.7.3.      Market Revenue and Forecast, By Application (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Test Type (2016-2030)

10.4.2.  Market Revenue and Forecast, By Service Provider (2016-2030)

10.4.3.  Market Revenue and Forecast, By Application (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.4.4.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.4.4.3.      Market Revenue and Forecast, By Application (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.4.5.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.4.5.3.      Market Revenue and Forecast, By Application (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.4.6.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.4.6.3.      Market Revenue and Forecast, By Application (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.4.7.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.4.7.3.      Market Revenue and Forecast, By Application (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Test Type (2016-2030)

10.5.2.  Market Revenue and Forecast, By Service Provider (2016-2030)

10.5.3.  Market Revenue and Forecast, By Application (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.5.4.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.5.4.3.      Market Revenue and Forecast, By Application (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Test Type (2016-2030)

10.5.5.2.      Market Revenue and Forecast, By Service Provider (2016-2030)

10.5.5.3.      Market Revenue and Forecast, By Application (2016-2030)

Chapter 11.  Company Profiles

11.1.              Qiagen

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Quest Diagnostics, Inc.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              OPKO Health, Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Abbott

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Charles River Laboratories International, Inc.

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Cinven

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Arup Laboratories

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Sonic Healthcare

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Laboratory Corporation of America Holdings (LabCorp)

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           NeoGenomics Laboratories, Inc.

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

11.11.           Fresenius Medical Care

11.11.1.               Company Overview

11.11.2.               Product Offerings

11.11.3.               Financial Performance

11.11.4.               Recent Initiatives

11.12.           DaVita, Inc.

11.12.1.               Company Overview

11.12.2.               Product Offerings

11.12.3.               Financial Performance

11.12.4.               Recent Initiatives

11.13.           Siemens Healthcare GmbH

11.13.1.               Company Overview

11.13.2.               Product Offerings

11.13.3.               Financial Performance

11.13.4.               Recent Initiatives

11.14.           Viapath Group LLP

11.14.1.               Company Overview

11.14.2.               Product Offerings

11.14.3.               Financial Performance

11.14.4.               Recent Initiatives

11.15.           SGS SA

11.15.1.               Company Overview

11.15.2.               Product Offerings

11.15.3.               Financial Performance

11.15.4.               Recent Initiatives

11.16.           Almac Group

11.16.1.               Company Overview

11.16.2.               Product Offerings

11.16.3.               Financial Performance

11.16.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Report Details

  • Report Code:37442
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:October 2022
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers